Meningiomas are the second common Central Nervous System (CNS) neoplasm, and are the most common benign intracranial tumor. They approximately constitute up to 30% of all intracranial tumors. They arise from the arachnoidal coverings of brain. Presentation varies and depends on size, number and location of tumors. Symptoms include those related to increased in intracranial pressure, local irritative features including seizure and local pressure effect to eloquent areas, white matter tracts and cranial nerves. Management of meningiomsa is always challenging and multi-disciplinary approaches includes surgery, radiotherapy and possible chemotherapy and immunotherapy. Among radiation therapy treatment, stereotactic radiosurgery (SRS) or stereotactic radiosurgery (SRT) is getting the popularity compared to traditional conformal radiotherapy with comparable tumor control rate.
Part of the book: Brain Tumors
Drug resistant epilepsy (DRE) is not an uncommon clinical condition. DRE could cause disabling seizures and even sudden unexpected death in epilepsy (SUDEP). Pre-surgical evaluation is necessary to for surgical treatment to cure or palliative epilepsy. If feasible, surgical excision of an epileptic focus provides the best chance of cure. However, the standard non-invasive workup could not always identify the epileptic focus. Stereotactic EEG (SEEG) is an invasive EEG that could provide the spatial and temporal progression of epileptic discharge so that we could localize or lateralise the epileptic focus more easily. This chapter aims to illustrate the principle of SEEG, the methods of SEEG electrode insertion, the usual white matter tract pathway that epileptic discharge progresses. It also discusses the therapeutic use of SEEG in lesioning with radiofrequency ablation (RFA), as well as the future potential as part of the brain-computer interface (BCI).
Part of the book: Advances in Electroencephalography and Brain Connectome